A
Agilent Technologies, Inc.Healthcare · $48.8B market cap
Verdict
Share price
$167.78
close of Oct 3, 2026
Fair value
$92.13
Sticker Price
Payback Price
$36.85
buy price
A is Overpriced: at $167.78 it trades 82% above its fair value of $92.13. Its buy price (Payback Price) is $36.85, 78% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.
How we valued it
Owner Earnings. Earnings grow slowly (under 7% a year), but cash flow is steady, so we value it on its cash flow instead of its earnings.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow A
Get notified when it reaches its buy price of $36.85. Free.
Create a free accountSuperinvestors
2 of the investors we track hold A. In Q2 2026, 1 trimmed. Who we track
William Von Mueffling
Cantillon Capital Management · as of Q2 2026
$16.8M
126,437 shares
Greenhaven Associates
Greenhaven Associates · as of Q2 2026
$1.4M
10,700 shares
Moves in Q2 2026
Trimmed: William Von Mueffling
Insider activity
Since Jun 26, 2026: no open-market purchases, 1 sale worth $96K and 2 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Other filings
About Agilent Technologies, Inc.
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced…
Medical - Diagnostics & Research
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works